DIAMEDICA ANNOUNCES PRICING OF INITIAL PUBLIC OFFERING AND NASDAQ LISTING

world news, trump, u.s., business news, stock market, entertainment news, business news, company news, market, commodities, commodity, Africa news

MINNEAPOLIS, Dec. 07, 2018 (GLOBE NEWSWIRE) — DiaMedica Therapeutics Inc. (“DiaMedica”) (NASDAQ:DMAC) (TSX-V:DMA), a clinical stage biopharmaceutical company, announced today the pricing of its initial public offering…

Advertisements